Krzysztof Selmaj Selected Research

Macular Edema

2/2010

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Krzysztof Selmaj Research Topics

Disease

49	Multiple Sclerosis 12/2023 - 01/2002
28	Relapsing-Remitting Multiple Sclerosis 12/2023 - 11/2003
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2014 - 12/2002
4	Infections 01/2022 - 10/2015
4	Neoplasms (Cancer) 01/2017 - 01/2006
3	Inflammation (Inflammations) 03/2022 - 12/2002
3	Atrophy 03/2022 - 10/2008
3	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 02/2008
3	Necrosis 01/2006 - 11/2002
2	Exanthema (Rash) 10/2015 - 06/2013
2	Flushing 09/2015 - 09/2012
1	COVID-19 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Ganglion Cysts (Ganglion) 01/2022
1	Fever (Fevers) 10/2021
1	Splenomegaly 10/2021
1	Hypertriglyceridemia 10/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 10/2021
1	Cytopenia 10/2021
1	Chronic Progressive Multiple Sclerosis 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Transposition of Great Vessels (Great Vessels Transposition) 12/2016
1	Congenital Heart Defects (Congenital Heart Defect) 12/2016
1	Spontaneous Abortion (Miscarriage) 12/2016
1	Pneumonia (Pneumonitis) 07/2016
1	Ulcerative Colitis 07/2016
1	Urinary Tract Infections (Urinary Tract Infection) 07/2016
1	Injection Site Reaction 12/2015
1	Eczema 10/2015
1	Autoimmune Hepatitis 05/2014
1	Neuromyelitis Optica (Devic's Disease) 07/2013
1	Psoas Abscess 06/2013
1	Abdominal Pain (Pain, Abdominal) 09/2012
1	Diarrhea 09/2012
1	Nausea 09/2012
1	Hypoglycemia (Reactive Hypoglycemia) 10/2010
1	Diabetic Angiopathies (Diabetic Angiopathy) 10/2010
1	Uremia 10/2010
1	Acidosis 10/2010
1	Bradycardia 02/2010
1	Hypertension (High Blood Pressure) 02/2010
1	Atrioventricular Block 02/2010
1	Macular Edema 02/2010
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 08/2008

Drug/Important Bio-Agent (IBA)

10	Dimethyl FumarateIBA 01/2022 - 09/2012
7	Interferon beta-1a FDA Link 01/2018 - 11/2003
5	Glatiramer Acetate (Copaxone)FDA Link 10/2021 - 05/2006
5	Daclizumab (Zenapax)FDA Link 10/2020 - 06/2013
5	AntigensIBA 03/2015 - 06/2004
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 02/2010
4	ocrelizumabIBA 10/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2007
4	GadoliniumIBA 01/2018 - 09/2014
4	Peptides (Polypeptides)IBA 10/2014 - 10/2007
3	teriflunomideIBA 01/2022 - 01/2020
3	daclizumab HYPIBA 10/2015 - 06/2013
3	InterferonsIBA 11/2014 - 05/2006
3	LigandsIBA 01/2010 - 11/2002
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2008 - 12/2005
2	Cladribine FDA LinkGeneric 12/2023 - 01/2022
2	diroximel fumarateIBA 12/2023 - 01/2020
2	TabletsIBA 12/2023 - 01/2022
2	Natalizumab (Tysabri)FDA Link 01/2023 - 07/2013
2	Monoclonal AntibodiesIBA 01/2023 - 08/2010
2	Retinaldehyde (Retinal)IBA 01/2022 - 10/2008
2	AntibodiesIBA 01/2021 - 10/2017
2	FumaratesIBA 01/2020 - 02/2014
2	siponimodIBA 09/2016 - 08/2013
2	EnzymesIBA 07/2016 - 02/2010
2	Transaminases (Aminotransferases)IBA 10/2015 - 09/2012
2	Notch ReceptorsIBA 01/2010 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 01/2008 - 09/2004
2	ChemokinesIBA 09/2004 - 12/2002
1	nitazoxanide (NTZ)FDA Link 01/2023
1	Biosimilar PharmaceuticalsIBA 01/2023
1	temelimabIBA 03/2022
1	ublituximabIBA 01/2022
1	Ferritins (Ferritin)IBA 10/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021
1	ofatumumab FDA Link 01/2020
1	Cytidine Diphosphate (CDP)IBA 12/2018
1	CholesterolIBA 10/2017
1	LipidsIBA 10/2017
1	Lisinopril (Prinivil)FDA LinkGeneric 12/2016
1	Neuroprotective AgentsIBA 06/2016
1	Generic DrugsIBA 12/2015
1	Interleukin-2 (IL2)IBA 10/2015
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 03/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2015
1	Indicators and Reagents (Reagents)IBA 12/2014
1	Chemokine ReceptorsIBA 11/2014
1	Therapeutic UsesIBA 08/2013
1	Interferon-betaIBA 04/2011
1	Uremic ToxinsIBA 10/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2010
1	Glucose (Dextrose)FDA LinkGeneric 10/2010
1	Alemtuzumab (Campath)FDA Link 08/2010
1	myosin-binding protein CIBA 08/2008

Therapy/Procedure

11	Therapeutics 01/2023 - 11/2007
1	Subcutaneous Injections 06/2013